Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AAAS | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
mRNA | ABCA3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | ABCD1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | ABHD14A-ACY1 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |
mRNA | ABHD17C | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
mRNA | ABHD18 | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-07 |
mRNA | ABHD2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ABO | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | AC002310.11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | AC002310.13 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |